These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 9539333

  • 1. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB, Daniel SE, Blunt SB.
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [Abstract] [Full Text] [Related]

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 3. DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?
    Kingsbury AE, Mardsen CD, Foster OJ.
    Mov Disord; 1998 Nov 19; 13(6):877-84. PubMed ID: 9827610
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 19; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 6. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A.
    Int Rev Neurobiol; 2007 Nov 19; 82():235-46. PubMed ID: 17678964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul 19; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P, Schulz JB.
    Cell Tissue Res; 2004 Oct 19; 318(1):149-61. PubMed ID: 15338271
    [Abstract] [Full Text] [Related]

  • 13. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F.
    No To Shinkei; 1993 Nov 19; 45(11):1033-8. PubMed ID: 8135950
    [Abstract] [Full Text] [Related]

  • 14. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.
    Tatton NA.
    Exp Neurol; 2000 Nov 19; 166(1):29-43. PubMed ID: 11031081
    [Abstract] [Full Text] [Related]

  • 15. Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.
    Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK, Muthane U.
    Neuroscience; 2009 Mar 03; 159(1):236-45. PubMed ID: 19135503
    [Abstract] [Full Text] [Related]

  • 16. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K, Hayashi M, Fukutani Y, Miyazu K, Shiozawa M, Muramori F, Aoki T, Koshino Y.
    Clin Neuropathol; 1999 Mar 03; 18(5):240-9. PubMed ID: 10505433
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
    Anglade P, Vyas S, Hirsch EC, Agid Y.
    Histol Histopathol; 1997 Jul 03; 12(3):603-10. PubMed ID: 9225140
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S.
    Parkinsonism Relat Disord; 2005 Jun 03; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [Abstract] [Full Text] [Related]

  • 19. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ.
    Exp Neurol; 1993 Nov 03; 124(1):103-18. PubMed ID: 8282068
    [Abstract] [Full Text] [Related]

  • 20. Cell death mechanisms in Parkinson's disease.
    Jellinger KA.
    J Neural Transm (Vienna); 2000 Nov 03; 107(1):1-29. PubMed ID: 10809400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.